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Abstract	Sepsis	affects	millions	of	people	worldwide	each	year.		It	occurs	when	a	normal	human	immune	response	to	a	bacterial,	viral	or	fungal	infection	becomes	dysfunctional	and	triggers	widespread	inflammation	that	results	in	severe	tissue	damage	that	leads	to	organ	failure,	shock,	and	death.	Sepsis,	requires	immediate	treatment	and	has	a	high	readmission	rate	for	survivors.	It	is	also	one	of	the	most	expensive	conditions	to	treat.	In	2013,	there	were	more	than	1.6	million	cases	of	sepsis	in	the	United	States	with	a	financial	cost	of	more	than	$23	billion.	Sepsis	was	first	described	in	antiquity,	and	given	its	current	name,	by	the	ancient	Greek	physician	Hippocrates.	Despite	its	long	medical	history,	severity,	and	financial	burden,	the	causes	of	sepsis	are	not	well	understood,	and	there	is	no	standard	approach	to	diagnosis	and	treatment.		The	definition	of	sepsis,	the	characterization	of	its	clinical	stages,	and	sepsis	monitoring	tools	have	changed	three	times	in	the	past	25	years,	most	recently	in	March	2016.	The	universal	adoption	of	this	latest	definition,	sepsis-3,	and	a	screening	tool,	qSOFA,	are	currently	under	debate	in	the	medical	community.	A	means	to	rapidly	identify	and	treat	sepsis	could	reduce	the	five	million	deaths	due	to	sepsis	each	year	worldwide.	This	paper	reviews	the	evolution	of	the	definition	of	sepsis	and	the	controversy	surrounding	the	sepsis-3	definition	and	the	sepsis	screening	tool,	qSOFA.		
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I.		Introduction 	 	Sepsis	is	one	of	the	oldest,	costliest,	and	most	devastating	medical	conditions	in	the	world.	Sepsis	was	first	described	in	ancient	Egypt	almost	5,000	years	ago	and	given	its	current	name	by	the	Greek	physician	Hippocrates	about	2,400	years	ago	(Botero	and	Pérez,	2012).	In	2013,	the	annual	financial	burden	of	sepsis	in	the	United	States	was	more	than	$23	billion.	Despite	its	long	history	and	its	current	impact	on	society,	sepsis	as	a	medical	condition	is	not	well	understood.	The	definition	is	under	current	revision	(Shankar-Hari	et	al.,	2016;	Simpson,	2016;	Cortés-Puch	and	Hartog,	2016;	Abraham,	2016);	there	is	no	gold	standard	diagnostic	test	for	sepsis,	nor	is	there	a	universally	adopted	treatment	(Singer	et	al.,	2016).	Along	with	revising	the	definition,	there	is	a	search	for	the	best	screening	tool	to	identify	sepsis.		A	medical	task	force	has	utilized	the	recent	availability	of	large	datasets	of	patients	to	compare	and	validate	several	screening	tools	for	sepsis.	These	tools	were	used	to	explore	more	than	one	million	patient	electronic	healthcare	records	(EHR),	which	had	a	known	number	of	patients	with	sepsis	(Seymour,	et	al.,	2016).	This	use	of	a	data	science	approach	to	validating	a	screening	tool	for	sepsis	is	a	promising	area	of	research.	Here	we	describe	the	severity	of	sepsis,	its	evolving	definition,	and	the	screen	tool,	qSOFA.		
A.	The	Severity	of	Sepsis	Sepsis	is	a	significant	cause	of	healthcare	costs	and	mortality	rates.	Worldwide,	an	estimated	31.5	million	people	are	treated	each	year	for	sepsis	of	which	5.3	million	end	up	dying	from	sepsis	(Fleischmann,	et	al.,	2016).	In	the	United	States,	there	are	about	1.6	million	cases	of	sepsis	each	year	with	more	than	258,000	deaths,	which	averages	to	one	person	dying	of	sepsis	every	two	minutes	(Sepsis	Alliance,	2016).	The	financial	cost	of	treating	sepsis	is	staggering.	The	2015	Healthcare	Cost	and	Utilization	Project	(HUCP)	Statistical	Brief	places	sepsis	as	the	most	expensive	condition	treated	in	US	hospitals	at	$23.7	billion	(Torio	and	Andrews,	2015).	Sepsis	accounts	for	40	percent	of	all	ICU	costs	in	the	United	States,	and	the	average	cost	for	treatment	of	ICU	patients	with	sepsis	is	six	times	greater	than	that	for	ICU	patients	that	do	not	have	sepsis.	Additionally,	patients	discharged	after	a	serious	bout	of	sepsis	have	a	62	percent	readmission	rate	(Sutton	&	Friedman,	2013;	Sepsis	Alliance,	2014).	This	information	on	the	severity	of	sepsis	is	summarized	in	figure	1.			
Figure	1:	Notable	facts	about	sepsis.		
Notable	 Details	High	cost	to	treat	 Most	expensive	condition	treated	in	the	United	States:	$23.7B	High	ICU	costs	 40%	of	all	ICU	costs	High	mortality	rate	 60%	for	septic	shock	High	readmission	rate	 62%	Rapid	decline	 Move	to	septic	shock	within	36	hours	of	identification		Challenging		 No	standard	diagnostic	test,	often	appears	with	comorbid	conditions			
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Research	has	shown	early	detection	of	sepsis	is	essential	in	saving	lives	and	reducing	cost	(Shore,	et	al.,	2007;	Jones,	et	al.,	2015;	Singer	et	al.,	2016).	The	Sepsis	Alliance	estimate	that	80%	of	deaths	due	to	sepsis	could	be	prevented	with	rapid	diagnosis	and	treatment	(Sepsis	Alliance,	2016).		
II.		The	Evolving	Definition	and	Monitoring	of	Sepsis	
	The	definition	of	sepsis	has	shifted	over	time.	Originally	sepsis	was	thought	to	be	an	internal	rotting	or	decaying.	This	was	due	to	the	smell	of	those	afflicted	(Funk,	et	al.,	2009).	Hippocrates	applied	the	Greek	word	for	decay—sepsis,	meaning	decay	or	to	rot—to	this	medical	condition.	The	development	of	medical	hygiene	and	the	germ	theory	in	the	late	1800s	by	Louis	Pasteur,	Joseph	Lister,	and	Robert	Kock	helped	change	the	viewpoint	of	sepsis	from	internal	decay	to	originating	from	a	harmful	microorganism.	In	1914,	Hugo	Schottmüller	laid	the	foundation	for	a	modern	definition	of	sepsis	when	he	wrote,	“Sepsis	is	present	if	a	focus	has	developed	from	which	pathogenic	bacteria,	constantly	or	periodically,	invade	the	blood	stream	in	such	a	way	that	this	causes	subjective	and	objective	symptoms”	(Rittirsch	et	al.,	2008).	
	As	sepsis	became	more	common	in	ICUs,	the	role	of	the	patient’s	immune	response	became	a	greater	focal	point	(Bone	et	al.,	1992).	In	1992,	a	conference	was	held	by	the	Society	of	Critical	Care	Medicine	and	the	American	College	of	Chest	Physicians	to	address	the	lack	of	consensus	regarding	the	definition	of	sepsis	and	the	difficulties	this	created	in	studies	and	treatment.	This	conference	and	its	outcomes	are	now	referred	to	as	sepsis-1.		This	was	followed	by	sepsis-2	in	2002	and	sepsis-3	in	2016.		Key	outcomes	from	the	sepsis-1	conference	(Bone	et	al.,	1992):	
• The	establishment	of	the	term	“systemic	inflammatory	response	syndrome”	(SIRS)	was	considered	a	clinical	stage	of	sepsis.		
• Key	definitions	for	sepsis	were	established	(see	below).		
• No	definable	presence	of	bacterial	infection	was	required	to	diagnose	sepsis.		
• The	terms	“severe	sepsis”	and	“septic	shock”	were	introduced	to	differentiate	degrees	of	severity.			Key	definitions	established	at	the	sepsis-1	conference:	
• Sepsis	results	from	a	host’s	systemic	inflammatory	response	syndrome	(SIRS)	to	infection.		
• Severe	sepsis	is	sepsis	associated	with	organ	dysfunction,	hypoperfusion,	or	hypotension.	
• Septic	shock	is	sepsis-induced	hypotension	persisting	despite	adequate	fluid	resuscitation.		The	sepsis-1	conference	also	established	four	clinical	stages	or	steps.	Each	stage	had	specific	clinical	indicators	(see	figure	2)	as	well	their	challenges	for	healthcare	providers.	The	first	stage	is	SIRS	(systemic	inflammatory	response	syndrome)	and	is	defined	by	the	presence	of	at	least	two	of	the	following	four	indicators:	(1)	a	body	temperature	above	
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38.0°	C	or	below	36.0°	C;	(2)	a	heart	rate	above	90	beats/minute;	(3)	a	respiratory	rate	above	20	breaths	per	minute;	(4)	a	white	blood	cell	count	higher	than	12,000	or	lower	than	4,000	cells	per	microliter.			If	an	infection	is	confirmed	or	suspected,	then	the	diagnosis	changes	from	SIRS	to	sepsis.	As	sepsis	progresses	from	one	stage	to	another,	there	is	a	corresponding	increase	in	the	mortality	rate	with	septic	shock	having	the	highest.	Figure	2	lists	the	30-day	mortality	rates	published	for	SIRS	and	sepsis	(Rangel-Fausto	et	al.,	1995)	and	those	published	for	severe	sepsis	and	septic	shock	(Schoenberg,	et	al.,	1998).				Each	of	the	four	stages	listed	in	figure	2	have	been	used	at	one	time	or	another	to	define	sepsis.	For	example,	in	ancient	times,	sepsis	was	identified	near	then	end	of	a	person’s	life	when	untreated	the	smell	of	rotting	became	apparent.	This	would	be	known	as	septic	shock	today.		Then	in	1915	the	definition	of	sepsis	focused	on	the	infection	in	stage	2	until	this	shifted	to	stage	1,	SIRS,	in	1989.		The	most	recent	definition,	sepsis-3,	focuses	on	the	beginning	of	organ	failure	in	stage	3,	severe	sepsis.		
Figure	2:	Mortality	rates	within	30	days	of	diagnosis.		
	 Stage	1:		
SIRS	
Stage	2:	
Sepsis	
Stage	3:	
Severe	Sepsis	
Stage	4:	
Septic	Shock	
Mortality	
Rate	
7%	 16%	 40%	 							>	50%	
Clinical	
Indicator	
Flu-like	symptoms	 SIRS	+	infection	 Sepsis	+	signs	of	organ	failure	 Persistent	severe	sepsis	
When	stage	
was	used	to	
define	sepsis	
1989	-	2015	Sepsis-1	&-2	 	1915	-	1989	Pre-Sepsis-1		 2016	-	present	Sepsis-3			 400BC	–	1915	Hippocrates	
Challenges	
for	each	
stage	
Misidentification:	inflammation	could	be	due	to	a	wide	variety	of	other	medical	conditions.	
Time:	It	could	take	days	to	verify	source	of	infection.	
Treatment:		Limited	treatment	options	when	organs	begin	to	fail.	
High	mortality	rate:	Often	too	late	for	successful	treatment.			
A.		Sepsis-2	(2001)		In	2001,	a	second	sepsis	definition	consensus	task	force	was	sponsored	by	the	Society	of	Critical	Care	Medicine,	European	Society	of	Intensive	Care	Medicine,	American	College	of	Clinical	Pharmacy,	American	Thoracic	Society,	and	the	Surgical	Infection	Society.	The	consensus	task	force	was	formed	to	review	the	clinical	progress	made	in	treating	sepsis	and	sepsis-1	definition.	The	task	force	recommended:		
• keeping	the	sepsis-1	definition,	but	recognize	it	has	limitations;		
• expanding	the	list	of	diagnostic	criteria	for	sepsis;	and		
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• recognizing	the	separate	characteristics	or	stages	of	sepsis	designated	by	the	acronym	PIRO:	predisposition,	infection,	response	to	the	infectious	challenge,	and	
organ	dysfunction	(Levy	et	al.,	2003).	The	expanded	list	of	diagnostic	criteria	of	sepsis	included	21	bedside	or	laboratory	tests	designed	to	indicate	either	inflammation	or	organ	dysfunction.			
B.	Sepsis	Early	Warning	Systems		Since	the	introduction	of	sepsis-2,	there	has	been	an	increase	in	the	use	of	organ	failure	or	mortality	scoring	systems	also	known	as	early	warning	score	(EWS)	systems.		These	EWS	systems	are	used	in	most	ICUs	as	a	method	to	triage	the	severity	of	critically	ill	patients.	They	are	bedside	evaluations	designed	to	provide	a	likely	mortality	rate	within	28	to	30	days.	Several	of	these	EWS	systems	were	developed	in	line	with	the	sepsis-1	and	sepsis-2	definitions.		The	EWS	systems	used	in	ICUs	and	adopted	to	monitor	sepsis	include:		
• APACHE	II	(the	Acute	Physiology	and	Chronic	Health	Evaluation	II)	Score,	introduced	in	1985,		
• MEWS	(the	Modified	Early	Warning	Score),	developed	in	1999	as	a	modification	of	the	Morgan’s	Early	Warning	Score	(Morgan	et	al.,	1997).		
• MEDS	(see	figure	3	and	4),	and		
• SOFA	(the	Sepsis-related	Organ	Failure	Assessment)	(Vincent,	et	al.,	1996).		To	illustrate	a	EWS,	the	scores	used	to	determine	a	patient’s	mortality	rate	using	MEDS	is	shown	below.	Figure	3	is	the	checklist	used	to	determine	the	score	and	figure	4	shows	the	predicted	mortality	rate	based	on	the	score.	
	
Figure	3:	The	MEDS	EWS	checklist.	
Figure	4:	MEDS’	score	and	corresponding	mortality	rate.	
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	These	EWS	systems	has	helped	identify	the	progress	of	sepsis	in	patients	and	allowed	ICUs	to	determine	where	to	deploy	their	resources	and	staff.	The	use	of	EWS	is	significant	in	the	monitoring	of	sepsis,	especially	in	the	ICUs	where	up	to	40	percent	of	the	cost	can	be	due	to	treating	patients	with	sepsis.		Along	with	these	early	warning	systems,	sepsis	awareness	campaigns	have	been	shown	to	be	beneficial.	The	Society	of	Critical	Care	Medicine	and	the	European	Society	of	Intensive	Care	Medicine	provide	direction	for	the	Surviving	Sepsis	Campaign,	which,	in	2009,	helped	achieve	a	25	percent	reduction	in	sepsis	mortality	through	awareness	and	education	about	sepsis,	especially	among	healthcare	providers	(Dellinger	et	al.,	2008).	The	Sepsis	Alliance,	a	voluntary	health	organization	founded	in	2004,	is	raising	awareness	of	sepsis	among	healthcare	providers	and	the	general	public.	This	included	launching	sepsis	awareness	month,	September,	helping	launch	the	global	sepsis	alliance,	the	heroes	of	sepsis	celebration,	and	designating	September	13	as	world	sepsis	day.	The	heroes	of	sepsis	celebration	focuses	on	recognizing	organizations	and	individuals	that	have	contributed	to	advancing	sepsis	research	and	education.	This	event	brings	together	survivors	with	healthcare	providers.	Damian	Mingle,	one	of	the	authors	of	this	paper,	was	a	finalist	for	the	2016	hero	of	sepsis.		
	
C.	Sepsis-3	(2016)		In	2014,	the	European	Society	of	Intensive	Care	Medicine	(ESICM)	and	the	Society	of	Critical	Care	Medicine	(SCCM)	convened	a	task	force	of	19	critical	care,	infectious	disease,	surgical,	and	pulmonary	specialists	with	the	aim	to	update	the	definitions	and	clinical	criteria	identifying	the	“septic	patient.”				The	sepsis-3	task	force	recognized	sepsis	as	more	complex	than	infection	and	inflammation	and	defined	sepsis	as	a	“life-threatening	organ	dysfunction	due	to	a	dysregulated	host	response	to	infection.”	In	this	new	definition	(sepsis-3),	the	host	response	resulting	in	organ	failure	from	an	infection	is	stressed	while	the	inflammation	stage	known	as	SIRS	in	sepsis-1	and	-2	has	been	removed.	The	task	force	included	advances	made	in	understanding	the	pathology,	management,	and	epidemiology	of	sepsis	as	well	as	an	analysis	of	over	one	million	patients.	The	results	published	in	the	February	2016	issue	of	JAMA,	the	Journal	of	the	American	Medical	Association,	reduced	the	clinical	stages	in	sepsis	from	the	four	described	in	figure	2	to	the	last	two	stages	(Singer	et	al.,	2016).	The	previous	of	clinical	stage	known	as	severe	sepsis	is	now	used	to	define	sepsis.		Sepsis	is	now	defined	as	“a	life-threatening	organ	dysfunction	caused	by	a	dysregulated	host	response	to	infection.”	(Singer	et	al.,	2016).	The	key	features	and	new	definition	for	sepsis	are	in	figure	5	below.		
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																																Figure	5:	Sepsis-3	key	features	and	definitions.	
 
Key	Feature		 Definition		
Two	clinical	stages	1.	Severe	sepsis	2.	Septic	shock			Introduces	a	new	diagnostic	tool,	quickSOFA,	or	qSOFA	
Sepsis	is	a	life-threatening	organ	dysfunction	caused	by	a	dysregulated	host	response	to	infection.	
Septic	shock	is	a	subset	of	sepsis	in	which	particularly	profound	circulatory,	cellular,	and	metabolic	abnormalities	are	associated	with	a	greater	risk	of	mortality	than	with	sepsis	alone.			To	determine	which	early	warning	signal	to	recommend,	the	sepsis-3	task	force	compared	a	variety	of	EWS	systems	used	to	monitor	sepsis.		The	results	showed	that	qSOFA	EWS	systems	was	similar	to	the	accuracy	to	most	EWS,	but	is	easier	to	use	and	more	accurate	in	locations	outside	of	or	prior	to	admissions	into	the	ICU.	Figure	6	has	the	qSOFA	scoring	system.	A	qSOFA	score	≥2	suggests	a	high	risk	of	poor	outcome	and	an	indication	that	these	patients	have	sepsis	and	should	have	their	lactate	levels	tested	for	evidence	of	organ	dysfunction.			
																											Figure	6:	qSOFA	scoring.		
Criteria	 Point	Value	Altered	mental	status	 +1	Respiratory	rate	>	or	=	22	 +1	Systolic	blood	pressure	<	or	=	100	 +1			To	validate	qSOFA	as	a	screening	and	monitoring	tool	for	sepsis,	scores	were	applied	to	a	large	set	of	electronic	health	record	data	which	contained	known	patients	with	sepsis.	The	dataset	used	contained	the	electronic	health	record	data	of	1.3	million	encounters	from	January	1,	2010,	to	December	31,	2012,	at	12	community	and	academic	hospitals	within	the	University	of	Pittsburgh	Medical	Center	health	system	in	southwestern	Pennsylvania	were	used	for	this	comparison.	The	predictive	validity	of	qSOFA	and	other	EWS	tool	were	compared	by	plotting	the	area	under	the	receiver	operating	characteristic	curve	(AUROC).	It	was	the	recent	availability	of	a	large	set	of	electronic	health	record	data	made	this	study	possible.		
D.		Controversy	surrounding	Sepsis-3	definition	The	definition	for	sepsis	developed	by	the	sepsis-3	task	force	and	qSOFA	have	not	been	universally	adopted.	Several	papers	and	letters	to	the	JAMA	editor	has	raised	concerns	(Sprung	&	Reinhart,	2016;	Kleinpell,	et	al,	2016;	Abraham,	E.,	2016).		A	few	of	the	major	concerns	about	the	sepsis-3	definition	include:		
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• A	focus	on	adult	patients	without	including	newborn	and	pediatric	patients.	
• Research	generated	from	patients	in	the	United	States	and	Europe	but	not	from	economically	poorer	countries.		
• A	task	force	without	experts	from	emergency	medicine	and	other	important	groups.	
• The	change	in	the	clinical	stages	of	sepsis,	making	comparisons	with	prior	research	about	sepsis	difficult.	The	past	25-year	body	of	sepsis	research	focused	on	four	clinical	stages	of	sepsis	and	the	new	definition	changes	this	to	two	clinical	stages.	
• Too	much	reliance	on	qSOFA	to	diagnose	sepsis.				
• A	lack	of	endorsement	by	all	societies	including	the	Latin	American	Sepsis	Institute,	American	College	of	Chest	Physicians,	and	American	College	of	Emergency	Physicians.	
	
III.		Area	of	Promising	Research	in	Sepsis	
	While	there	remains	controversy	surrounding	the	definition	of	sepsis,	key	advances	in	research	continue.		One	of	the	areas	of	promise	is	using	data	science	approaches	to	mine	insights	and	knowledge	from	large	databases	of	electronic	healthcare	records.		This	was	done	to	verify	and	test	qSOFA	and	other	EWS.		Several	hospitals	are	now	utilizing	computational	means	to	monitor	patients	within	the	ICU.	The	availability	of	large	sets	of	digital	healthcare	records	that	can	be	analyzed	with	data	science	approaches	is	able	to	provide	a	new	approach	to	the	rapid	identification	and	treatment	of	sepsis.			MIMIC	(Medical	Information	Mart	for	Intensive	Care)	is	a	large	database	freely	available	to	researchers.	It	contains	heath	data	from	over	40,000	ICU	patients	who	stayed	at	Beth	Israel	Deaconess	Medical	Center	between	2001	and	2012.	This	database	contains	lab	results,	electronic	documentation,	and	bedside	monitor	trends	and	waveforms.	Several	research	teams	have	explored	the	MIMIC	database	to	better	understand	sepsis	(Calvert	et	al.,	2016;	Henry	et	al.,	2016).	If	sepsis	can	be	rapidly	detected	and	treated,	the	financial	cost	and	patient	suffering	will	decrease.	
	
	
IV.		Summary	
	According	to	the	sepsis-3	definition	task	force,	the	process	of	defining	sepsis	remains	a	work	in	progress:	“As	is	done	with	software	and	other	coding	updates,	the	task	force	recommends	that	the	new	definition	be	designated	Sepsis-3,	with	the	1991	and	2001	iterations	being	recognized	as	Sepsis-1	and	Sepsis-2,	respectively,	to	emphasize	the	need	for	future	iterations.”	(Singer	et	al.,	2016).		The	evolving	definition	of	sepsis	can	be	seen	as	four	major	updates	to	its	original	definition	with	needs	for	future	iterations.	The	original	definition	began	in	antiquity	when	sepsis	was	named	and	defined	by	the	rotting	smell	of	its	victims.		This	was	updated	in	1917	when	the	definition	focused	on	infection	as	the	trigger	for	sepsis.	In	1992	the	sepsis’	definition	was	updated	again	and	this	time	the	focus	was	on	the	patient’s	systemic	inflammation	response	
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(sepsis-1).	In	2016,	sepsis’	definition	was	updated	a	fourth	time	to	focus	on	organ	dysfunction.	The	lack	of	universal	adaption	of	the	sepsis-3	definition	suggests	its	definition	will	evolve	again	as	a	future	iteration	suggested	by	the	sepsis-3	task	force.				This	updating	or	evolving	definition	reveals	several	important	factors	contributing	to	the	medical	condition	known	as	sepsis.		These	include	(1)	the	pathogen	that	triggers	sepsis;	(2)	the	patient’s	immune	response	to	the	pathogen;	and	(3)	the	patient’s	medical	history	and	condition	at	the	time	of	sepsis.	It	is	the	interplay	between	these	factors	that	make	each	case	of	sepsis	to	be	somewhat	unique	to	the	individual	and	their	current	medical	condition.			In	addition	to	its	evolving	definition,	sepsis	is	a	challenge	for	healthcare	providers	to	diagnosis	and	treat.		This	challenges	include:	
• The	lack	of	a	gold	standard	for	identification	and	treatment.		
• Symptoms	of	other	disorders	mask	that	of	sepsis	(see	appendix	A	for	list).	
• A	low	percentage	of	patients	have	sepsis	(~2%	of	emergency	room	patients	have	sepsis).	
• The	rapidly	progression	of	sepsis	to	a	fatal	outcome	
• A	high	mortality	rate		Sepsis	is	often	not	suspected	by	heath	care	providers.		The	clinical	symptoms	used	in	diagnosing	sepsis	(raised	temperature,	increased	breathing	rate,	and	mental	alertness)	do	not	rule	out	other	common	disorders.		In	fact,	a	number	of	disorders	appear	as	sepsis	(see	appendix	A).	Most	of	these	disorders	are	seen	in	a	higher	percentage	of	patients	entering	emergency	rooms	than	sepsis.	As	a	result	of	these	challenges,	sepsis	is	often	diagnosed	too	late	to	save	the	patient.		Although	awareness	campaigns	and	ICU	early	warning	systems	have	been	shown	to	be	beneficial.			The	rapid	identification	and	treatment	of	sepsis	is	critical.	In	spite	of	these	challenges,	several	investigators	consider	sepsis	reversible	and	preventable	(Levy,	et	al.,	2004;	Marshall,	2015).		If	sepsis	can	be	rapidly	detected	and	treated,	the	financial	cost	and	patient	suffering	will	decrease.	More	exploration	of	large	electronic	patient	databases	involving	patients	with	sepsis,	such	as	MIMIC,	using	data	science	approaches	are	needed.	Data	science	approaches,	such	as	machine	learning,	predictive	analytics,	and	data	mining,	are	beginning	to	be	applied	to	difficult	healthcare	problems	(Holzinger	and	Jurisica,	2014,	Chennamsetty,	et	al.,	2015)		The	result	of	which	should	lead	to	insights	into	the	best	ways	to	identify,	monitor	and	treat	for	patients	with	sepsis.				
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 Appendix	A:		
List	of	disorder	often	diagnosed	instead	of	sepsis*		Cholera		Typhoid	fever	Salmonella	gastroenteritis	Shigella	dysenteriae	Staphylococcal	food	poisoning	Escherichia	coli	infections	Colitis	Enteritis	and	gastroenteritis	Tuberculosis		Bubonic	plague	Cutaneous	anthrax	Brucellosis	Glanders	Melioidosis	Listeriosis	Leprosy	Pulmonary	mycobacteria	diseases	Faucial	diphtheria	Whooping	cough		Streptococcal	sore	throat	Erysipelas	Meningococcal	infection	Tetanus	Erythrasma	Gas	gangrene	Streptococcus	infection		Syphilis	Gonococcal	infections	Leptospirosis	icterohemorrhagica	Vincent's	angina	Yaws	Primary	lesions	of	pinta	Other	spirochetal	infection	Tinea	barbae	and	tinea	capitis	Dermatomycosis	Candidal	Coccidioidomycosis	Histoplasmosis	Blastomycosis	Other	mycoses	Opportunistic	mycoses	Bacterial	meningitis	
Meningitis		Intracranial/intraspinal	abscess	Pericarditis		Acute	and	subacute	endocarditis	Phlebitis	and	thrombophlebitis	Acute	sinusitis	Acute	pharyngitis	Acute	tonsillitis	Acute	laryngitis	and	tracheitis	Acute	upper	respiratory	infections		Pneumococcal	pneumonia	Other	bacterial	pneumonia	Bronchopneumonia	Pneumonia	Bronchiectasis	Empyema	Abscess	of	lung	and	mediastinum	Appendicitis	Abscess	of	anal	and	rectal	regions	Peritonitis		Infections	of	kidney	Urethritis		Acute	salpingitis	and	oophoritis	Inflammatory	diseases	of	prostate	Inflammatory	diseases	of	uterus		Inflammatory	disease	of	cervix	Inflammatory	disease	of	vagina	Inflammatory	disease	of	vulva	Cellulitis	and	abscess	of	finger	Acute	lymphadenitis,	unspecified	Osteomyelitis	periostitis		Other	functional	bladder	disorders	Abscess	of	liver	Portal	pyemia	Acute	cholecystitis	Urinary	tract	infection	Pyogenic	arthritis	Bacteremia	Postoperative	infection		Bronchitis		Diverticulitis		Perforation	of	intestine	
*This	list	is	adapted	from	Iwashyna	et	al.,	2014.				
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